AQST
Aquestive Therapeutics Inc
3.90$
-3.7%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Aquestive Therapeutics Inc (AQST) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/19/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Financial Statements and Exhibits | View report ↗ |
| 10/15/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 10/14/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Entry into a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 10/07/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 09/29/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report ↗ |
| 09/25/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 09/17/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/09/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/17/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/11/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/10/2026 | Current report (8-K) | Aquestive Therapeutics, Inc. (AQST): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.